During the assessment of a client's respiratory system, the nurse determines that the client's expiration phase is the same length as the inspiration phase. The client's respiratory rate is 14 per minute
The nurse would document this finding as: 1. obstructive breathing.
2. bradypnea.
3. respiratory distress.
4. normal.
4
Rationale 1: A client exhibiting obstructive breathing will have a prolonged expiration.
Rationale 2: Bradypnea is a term used to describe slow, regular respirations that are less than 10 per minute.
Rationale 3: These findings do not indicate that the client is experiencing respiratory distress.
Rationale 4: The finding describes eupnea, which is a normal breathing pattern.
You might also like to view...
The patient who has tested positive for a gene associated with breast cancer is concerned that this finding will affect her ability to get a government job position for which she has applied. How should the nurse respond to this concern?
1. "Surely there would be no way for the personnel department to find out that information." 2. "There is a federal law that prohibits genetic information from being used in employment decisions." 3. "Worrying about these concerns is not good for your health." 4. "It should be a problem only if you intend to use the insurance plan."
The nurse is preparing to assess an adult client suspected of having hyperthyroidism. Which assessment findings does the nurse anticipate? Select all that apply.
A. Constricted pupils. B. Temperature of 100.1°F C. Respiratory rate of 14 breaths per minute. D. Apical pulse: 120 bpm. E. Blood pressure: 162/92 mmHg.
Placebo effects are
A. psychological but not physical B. physical but not psychological C. neither physical nor psychological D. physical, psychological, or both
A nurse is teaching a woman about her menstrual cycle. The nurse states that __________ is the most important change that happens during the secretory phase of the menstrual cycle
a. Maturation of the graafian follicle b. Multiplication of the fimbriae c. Secretion of human chorionic gonadotropin d. Proliferation of the endometrium